8-KThe WireStrategic
Equity Issuance · Bylaw Amendment
Filed Jun 17, 2020 · 6y ago · Accession 0001213900-20-015132
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Lantern Pharma Inc.
- Ticker
- LTRN
- CIK
- 1763950
- Form type
- 8-K
- Filing date
- Jun 17, 2020
- Report date
- Jun 11, 2020
- Document
- ea123112-8k_lanternpharma.htm
- Size
- 3.1 MB